wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38743727-AAF059F2-A9D3-4DD9-8216-1F50C51DDDF2
Q38743727-AAF059F2-A9D3-4DD9-8216-1F50C51DDDF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38743727-AAF059F2-A9D3-4DD9-8216-1F50C51DDDF2
Sorafenib with ASC-J9® synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signals.
P2860
Q38743727-AAF059F2-A9D3-4DD9-8216-1F50C51DDDF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38743727-AAF059F2-A9D3-4DD9-8216-1F50C51DDDF2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4e5429c8e545381ab644732075cda22067cda557
P2860
New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.